List of bibliographic references indexed by Traitement
Number of relevant bibliographic references: 52.
[0-20] [
0 - 20][
0 - 50][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000241 (2011) |
Joseph Jankovic [États-Unis] | Diagnosis and treatment of psychogenic parkinsonism |
| 000430 (2011) |
José Baizabal [États-Unis] ; Richard Simpson [États-Unis] ; Joseph Jankovic [États-Unis] | Diagnosis and treatment of complications related to deep brain stimulation hardware |
| 000679 (2010) |
Fabrizio Stocchi [Italie] ; Olivier Rascol [France] ; Karl Kieburtz [États-Unis] ; Werner Poewe [Autriche] ; Joseph Jankovic [États-Unis] ; Eduardo Tolosa [Espagne] ; Paulo Barone [Italie] ; Anthony Lang [Canada] ; C Olanow [Italie, États-Unis] | Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE‐PD study |
| 000B31 (2009) |
Joseph Jankovic [États-Unis] | Disease-oriented approach to botulinum toxin use |
| 000C94 (2008) |
M York [États-Unis] ; M. Dulay [États-Unis] ; A. Macias [États-Unis] ; H Levin [États-Unis] ; R. Grossman [États-Unis] ; R. Simpson [États-Unis] ; Joseph Jankovic [États-Unis] | Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson’s disease |
| 000D21 (2008) |
C Olanow [États-Unis] ; Robert Hauser [États-Unis] ; Joseph Jankovic [États-Unis] ; William Langston [États-Unis] ; Anthony Lang [Canada] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Fabrizio Stocchi [Italie] ; Eldad Melamed [Israël] ; Eli Eyal [Israël] ; Olivier Rascol [France] | A randomized, double‐blind, placebo‐controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics |
| 000E69 (2007) |
Christopher Kenney [États-Unis] ; Richard Simpson [États-Unis] ; Christine Hunter [États-Unis] ; William Ondo [États-Unis] ; Michael Almaguer [États-Unis] ; Anthony Davidson [États-Unis] ; Joseph Jankovic [États-Unis] | Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders |
| 000E71 (2007) |
Joseph Jankovic [États-Unis] ; Mark Stacy [États-Unis] | Medical management of levodopa-associated motor complications in patients with parkinson's disease |
| 000E77 (2006-11) |
J Jankovic | Current strategies in treating the Parkinson's disease patient |
| 001066 (2005) |
Leo Metman [États-Unis] ; Shaun O [États-Unis] | Role of surgery in the treatment of motor complications |
| 001067 (2005) |
Katherine Widnell [États-Unis] ; Cynthia Comella [États-Unis] | Role of COMT inhibitors and dopamine agonists in the treatment of motor fluctuations |
| 001081 (2005) |
Cheryl Waters [États-Unis] | Other pharmacological treatments for motor complications and dyskinesias |
| 001086 (2005) |
C Olanow [États-Unis] ; Joseph Jankovic [États-Unis] | Neuroprotective therapy in Parkinson's disease and motor complications: A search for a pathogenesis‐targeted, disease‐modifying strategy |
| 001158 (2005) |
Ron Tintner [États-Unis] ; Prasad Manian [États-Unis] ; Polly Gauthier [États-Unis] ; Joseph Jankovic [États-Unis] | Pleuropulmonary fibrosis after long-term treatment with the dopamine agonist pergolide for Parkinson disease |
| 001161 (2005) |
Shaheda Azher [États-Unis] ; Joseph Jankovic [États-Unis] | Camptocormia : Pathogenesis, classification, and response to therapy |
| 001309 (2004) |
Markus Naumann [Allemagne] ; Wolfgang Jost [Allemagne] | Botulinum toxin treatment of secretory disorders |
| 001480 (2003) |
J Nutt [États-Unis] ; K Burchiel [États-Unis] ; C Comella [États-Unis] ; J Jankovic [États-Unis] ; A Lang [Canada] ; E Laws [États-Unis] ; A Lozano [Canada] ; R Penn [États-Unis] ; R Simpson [États-Unis] ; M Stacy [États-Unis] ; G Wooten [États-Unis] | Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD |
| 001482 (2003) |
Nicole Simpkins [États-Unis] ; Joseph Jankovic [États-Unis] | Neuroprotection in Parkinson disease |
| 001485 (2003) |
Madhavi Thomas [États-Unis] ; WEI DONG LE [États-Unis] ; Joseph Jankovic [États-Unis] | Minocycline and other tetracycline derivatives: A neuroprotective strategy in Parkinson's disease and Huntington's disease |
| 001546 (2002) |
William Ondo [États-Unis] ; Joel Levy [États-Unis] ; Kevin Vuong [États-Unis] ; Christine Hunter [États-Unis] ; Joseph Jankovic [États-Unis] | Olanzapine treatment for dopaminergic‐induced hallucinations |
| 001623 (2002) |
Joseph Jankovic [États-Unis] | Levodopa strengths and weaknesses |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/JankovicV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i -k "Traitement"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i \
-Sk "Traitement" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= JankovicV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= PascalFr.i
|clé= Traitement
}}
| This area was generated with Dilib version V0.6.19.
Data generation: Wed Feb 10 22:03:07 2016. Site generation: Tue Feb 13 16:14:27 2024 |  |
